デフォルト表紙
市場調査レポート
商品コード
1701426

臨床データ分析の市場規模、シェア、成長分析、展開別、タイプ別、ソリューション別、用途別、エンドユーザー別、地域別 - 産業予測 2025-2032年

Clinical Data Analytics Market Size, Share, and Growth Analysis, By Deployment (Cloud Based, On-Premise), By Type (Prescriptive, Descriptive), By Solution, By Application, By End Users, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
臨床データ分析の市場規模、シェア、成長分析、展開別、タイプ別、ソリューション別、用途別、エンドユーザー別、地域別 - 産業予測 2025-2032年
出版日: 2025年04月01日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

臨床データ分析市場規模は2023年に163億米ドルと評価され、2024年の178億8,000万米ドルから2032年には375億米ドルに成長し、予測期間(2025-2032年)のCAGRは9.7%で成長する見通しです。

世界の臨床データ分析市場は、ヘルスケアインフォマティクスの導入拡大とヘルスケア分野におけるデジタル変革に後押しされ、大きな成長を遂げています。この市場は、患者の転帰の向上、業務パフォーマンスの最適化、ヘルスケア提供の改善において極めて重要です。ヘルスケアデータ量の急増と分析技術の進歩が市場拡大の原動力となっています。主な成長促進要因としては、リアルタイムの洞察、予測分析、個別化医療に対する需要の高まりが挙げられます。しかし、データセキュリティの懸念、相互運用性の問題、熟練した専門家の不足といった課題が潜在的な抑制要因となっています。同市場は、大手企業間の戦略的提携、合併、買収によって特徴付けられ、現代ヘルスケアにおけるデータ情報に基づく意思決定の差し迫ったニーズを原動力として、臨床データ分析分野を継続的成長に位置付けています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制分析
  • 技術分析
  • ケーススタディ

臨床データ分析市場規模:展開別& CAGR(2025-2032)

  • 市場概要
  • クラウドベース
  • オンプレミス
  • ウェブベース

臨床データ分析市場規模:タイプ別& CAGR(2025-2032)

  • 市場概要
  • 規範的
  • 概要的
  • 予測的

臨床データ分析市場規模:ソリューション別& CAGR(2025-2032)

  • 市場概要
  • プラットフォーム
  • サービス
    • コンサルティングサービス
    • 統合および実装サービス
    • サポートおよびメンテナンスサービス

臨床データ分析市場規模:用途別& CAGR(2025-2032)

  • 市場概要
  • 臨床意思決定支援
  • 臨床試験
  • 規制コンプライアンス
  • その他の用途

臨床データ分析市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 製薬およびバイオテクノロジー企業
  • ヘルスケア提供者
  • ヘルスケア支払者
  • その他のエンドユーザー

臨床データ分析市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024年)

主要企業プロファイル

  • CitiusTech(India)
  • Veradigm(USA)
  • IQVIA(USA)
  • Health Catalyst(USA)
  • Optum(USA)
  • Prognos(USA)
  • Qventus(USA)
  • Pro Medicus(Australia)
  • Genomics(UK)
  • Relx Group(UK)
  • Parexel(USA)
  • Databricks(USA)
  • ExlService Holdings(USA)
  • Tempus Labs(USA)
  • SAS Institute(USA)
  • MedeAnalytics(USA)
  • Inovalon(USA)
  • Clarify Health Solutions(USA)
  • Arcadia(USA)
  • Ayasdi(USA)

結論と提言

目次
Product Code: SQMIG35G2264

Clinical Data Analytics Market size was valued at USD 16.3 billion in 2023 and is poised to grow from USD 17.88 billion in 2024 to USD 37.5 billion by 2032, growing at a CAGR of 9.7% during the forecast period (2025-2032).

The Global Clinical Data Analytics market is witnessing significant growth fueled by the increasing adoption of healthcare informatics and the digital transformation within the healthcare sector. This market is crucial in enhancing patient outcomes, optimizing operational performance, and improving healthcare delivery. The surge in healthcare data volume, alongside advancements in analytics technologies, is driving market expansion. Key growth drivers include the rising demand for real-time insights, predictive analytics, and personalized medicine. However, challenges such as data security concerns, interoperability issues, and the scarcity of skilled professionals pose potential restraints. The market is characterized by strategic collaborations, mergers, and acquisitions among leading players, positioning the Clinical Data Analytics sector for continued growth, driven by the pressing need for data-informed decision-making in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Data Analytics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Data Analytics Market Segments Analysis

Global Clinical Data Analytics Market is segmented by Deployment, Type, Solution, Application, End Users and region. Based on Deployment, the market is segmented into Cloud Based, On-Premise, and Web-based. Based on Type, the market is segmented into Prescriptive, Descriptive and Predictive. Based on Solution, the market is segmented into Platforms and Services. Based on Application, the market is segmented into Clinical Decision Support, Clinical Trials, Regulatory Compliance and Other Applications. Based on End Users, the market is segmented into Pharmaceutical And Biotechnology Companies, Healthcare Providers, Healthcare Payers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Data Analytics Market

The Clinical Data Analytics market is significantly influenced by the rising digitization of healthcare data and the ongoing improvements in analytics technologies. As healthcare organizations seek real-time insights, predictive analytics, and tailored medicine solutions, the demand for clinical data analytics is surging. This shift not only enhances decision-making processes but also promotes improved patient outcomes and operational efficiency. Consequently, healthcare providers are increasingly implementing sophisticated data analytics solutions to meet these evolving needs, driving the growth and transformation of the clinical data analytics landscape within the industry.

Restraints in the Clinical Data Analytics Market

A significant constraint within the Clinical Data Analytics market is the intricate nature and diversity of healthcare records, which often encompass both dependent and unstructured data from multiple sources, complicating integration and analysis efforts. Additionally, concerns surrounding data security and patient privacy further impede market growth, as the healthcare sector is required to comply with stringent regulations to safeguard sensitive information. These challenges create obstacles for organizations aiming to effectively leverage clinical data, hindering their ability to derive meaningful insights and make informed decisions that could enhance patient outcomes and operational efficiency in the healthcare landscape.

Market Trends of the Clinical Data Analytics Market

The Clinical Data Analytics market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning algorithms, enabling healthcare organizations to extract profound insights from intricate datasets. This rising adoption facilitates advanced analytics that enhances decision-making processes, particularly in evidence-based research and real-world evidence applications. As healthcare systems strive to improve patient outcomes and operational efficiency, the emphasis on utilizing clinical data for informed decision-making is becoming increasingly vital. Moreover, the growing focus on personalized medicine and predictive analytics further fuels this trend, positioning AI and machine learning as essential tools for innovative healthcare solutions moving forward.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Analysis
  • Technology Analysis
  • Case Studies

Global Clinical Data Analytics Market Size by Deployment & CAGR (2025-2032)

  • Market Overview
  • Cloud Based
  • On-Premise
  • Web-Based

Global Clinical Data Analytics Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Prescriptive
  • Descriptive
  • Predictive

Global Clinical Data Analytics Market Size by Solution & CAGR (2025-2032)

  • Market Overview
  • Platforms
  • Services
    • Consulting Services
    • Integration And Implementation Services
    • Support And Maintenance Services

Global Clinical Data Analytics Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Clinical Decision Support
  • Clinical Trials
  • Regulatory Compliance
  • Other Applications

Global Clinical Data Analytics Market Size by End Users & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical And Biotechnology Companies
  • Healthcare Providers
  • Healthcare Payers
  • Other End Users

Global Clinical Data Analytics Market Size & CAGR (2025-2032)

  • North America (Deployment, Type, Solution, Application, End Users)
    • US
    • Canada
  • Europe (Deployment, Type, Solution, Application, End Users)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Deployment, Type, Solution, Application, End Users)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Deployment, Type, Solution, Application, End Users)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Deployment, Type, Solution, Application, End Users)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • CitiusTech (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Veradigm (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IQVIA (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Health Catalyst (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Optum (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prognos (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qventus (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pro Medicus (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genomics (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Relx Group (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Parexel (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Databricks (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ExlService Holdings (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tempus Labs (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SAS Institute (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedeAnalytics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inovalon (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Clarify Health Solutions (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arcadia (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ayasdi (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations